Rivastigmine for Alzheimer’s disease

The Cochrane Database of Systematic Reviews, April 2015

This Cochrane Systematic review aims to determine the clinical efficacy and safety of rivastigmine for patients with dementia of Alzheimer’s type.

Click here to access the full text paper and additional information.

Advertisements